Ovarian Cancer Follow-up: A Preliminary Comparison of 2 Approaches

International Journal of Gynecological Cancer

Volumn 27, Issue 1, 2017, Pages 59-68

  Lanceley, Anne ^a   Berzuini, Carlo ^b   Burnell, Matthew ^a   Gessler, Sue ^a,c   Morris, Stephen ^a   Ryan, Andy ^a   Ledermann, Jonathan A ^a,c   Jacobs, Ian ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Follow up; Nurse led; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL OUTCOME; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER CORE QUALITY OF LIFE QUESTIONNAIRE 30; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HEALTH CARE COST; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NURSE; OVARY CANCER; PATIENT SATISFACTION; PERITONEUM CANCER; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QLQ OV28 QUESTIONNAIRE; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UTERINE TUBE CARCINOMA; WARE PATIENT SATISFACTION QUESTIONNAIRE; MIDDLE AGED; NURSING; OVARY TUMOR; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT SATISFACTION; PRECISION MEDICINE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; YOUNG ADULT;

EID: 85010023479     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000877     Document Type: Article

References (32)

1. GLOBOCAN 2008. Estimated incidence, mortality and 5-yearprevalence: women. Available at: http://globocan.iarc.fr/factsheet.asp#WOMEN. Accessed July 31, 2015.
2. Aebi S, Castiglione M, ESMO Guidelines Working Group.Epithelial ovarian carcinoma: ESMO ClinicalRecommendations for diagnosis, treatment and follow-up. AnnOncol. 2008;19(suppl 2):ii14-ii16.
3. Leeson S, Stuart N, Sylvestre Y, et al. Gynaecological cancerfollow-up: national survey of current practice in the UK. BMJOpen. 2013;3:e002859.
4. Rustin GJ, van der Burg ME, Griffin CL, et al. Early versusdelayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): A randomised trial. Lancet. 2010;376:1155-1163.
5. Clarke T, Galaal K, Bryant A, et al. Evaluation of follow-upstrategies for patients with epithelial ovarian cancer followingcompletion of primary treatment. Cochrane Database Syst Rev.2014:CD006119.
6. Olaitan A, Murdoch J, Anderson R, et al. A critical evaluation ofcurrent protocols for the follow up of women treated forgynaecological malignancies. Int J Gynecol Cancer.2001;22:36-53.
7. Friedlander M, Butow P, Stockler M, et al. Symptom control inpatients with recurrent ovarian cancer: measuring the benefit ofpalliative chemotherapy in women with platinum refractory/resistant ovarian cancer. Int J Gynecol Cancer.2009;19:S44-S48.
8. Lydon A, Beaver K, Newbery C, et al. Routine follow-up aftertreatment for ovarian cancer in the United Kingdom (UK):patient and health professional views. Eur J Oncol Nurs.2009;13:336-343.
9. Howell D, Fitch MI, Deane KA. Women's experiences withrecurrent ovarian cancer. Cancer Nurs. 2003;26:10-17.
10. Anderson C, Carter J, Nattress K, et al. "The booklet helped menot to panic": A pilot of a decision aid for asymptomatic womenwith ovarian cancer and with rising CA-125 levels. Int J GynecolCancer. 2011;21:737-743.
11. McCorkle R, Dowd M, Ercolano E, et al. Effects of a nursingintervention on quality of life outcomes in post-surgical womenwith gynecological cancers. Psychooncology. 2009;18:62-70.
12. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluatingcomplex interventions: the new Medical Research Councilguidance. BMJ. 2008;337:a1655.
13. Available at: http://www.random.org.
14. Aaronson NK, Ahmedzai S, Bergman B, et al. The EuropeanOrganization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trialsin oncology. J Natl Cancer Inst. 1993;85:365-376.
15. Greimel E, Bottomley A, Cull A, et al. An international fieldstudy of the reliability and validity of a disease-specificquestionnaire module (the QLQ-Ov28) in assessing the qualityof life of patients with ovarian cancer. Eur J Cancer.2003;39:1402-1408.
16. Zigmond AS, Snaith RP. The Hospital Anxiety and DepressionScale. Acta Psychiatr Scand. 1983;67:361-370.
17. Ware JE Jr, Davies-Avery A, Stewart AL. The measurement andmeaning of patient satisfaction. Health Med Care Serv Rev.1978;1:3-15.
18. Tones K, Tilford S. Health Education: Effectiveness, Efficiencyand Equity. Chapman Hall: London; 1994.
19. Bandura A. Self-efficacy: toward a unifying theory ofbehavioral change. Psychol Rev. 1977;84:191-215.
20. Brennan J. Adjustment to cancerVcoping or personaltransition? Psychooncology. 2001;10:1-18.
21. Department of Health. National Schedule of Reference Costs V Year 2011-12 VNHS Trusts and NHS Foundation Trusts: NHS Own Costs. London: Department of Health 2012.Available at: https://www.gov.uk/government/publications/nhsreference-costs-financial-year-2011-to-2012. AccessedJanuary 12, 2015.
22. Barber J, Thompson S. Multiple regression of cost data: use ofgeneralised linear models. J Health Serv Res Policy.2004;9:197-204.
23. Rubin DB. Multiple Imputation for Nonresponse in Surveys.New York: John Wiley & Sons; 1987.
24. Leventhal H, Leventhal EA, Breland JY. Cognitive sciencespeaks to the "common-sense" of chronic illness management.Ann Beh Med. 2011;41:152-163.
25. Frew G, Smith A, Zutshi B, et al. Results of a quantitative surveyto explore both perceptions of the purposes of follow-up andpreferences for methods of follow-up delivery among serviceusers, primary care practitioners and specialist cliniciansafter cancer treatment. Clin Oncol (R Coll Radiol).2010;22:874-884.
26. Sheldon LK, Ellington L, Barrett R, et al. Nurse responsivenessto cancer patient expressions of emotion. Patient Educ Couns.2009;76:63-70.
27. Heaven C, Clegg J, Maguire P. Transfer of communication skillstraining from workshop to workplace: the impact of clinicalsupervision. Patient Educ Couns. 2006;60:313-325.
28. Berzuini C, Dawid D, Bernardinell L. Causality: StatisticalPerspectives and Application. Chichester: Wiley; 2012.
29. Jefford M, Rowland J, Grunfeld E, et al. Implementing improvedpost-treatment care for cancer survivors in England, withreflections from Australia, Canada and the USA. Br J Cancer.2013;108:14-20.
30. NHS ImprovementVCancer. Effective Follow up: Testing RiskStratified Pathways. Leicester: NHS Improvement; 2011;www.improvement.nhs.uk.
31. Havrilesky LJ, Abernethy AP. Quality of life in ICON7: need forpatients' perspectives. Lancet Oncol. 2013;14:183-185.
32. MistryM, Parkin DM, Ahmad AS, et al. Cancer incidence in theUnited Kingdom: projections to the year 2030. Br J Cancer.2011;105:1795-1803.